Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Operating Expenses (2016 - 2025)

Haemonetics (HAE) has 17 years of Operating Expenses data on record, last reported at $135.0 million in Q4 2025.

  • For Q4 2025, Operating Expenses changed 0.35% year-over-year to $135.0 million; the TTM value through Dec 2025 reached $531.3 million, down 3.64%, while the annual FY2025 figure was $527.1 million, 0.09% changed from the prior year.
  • Operating Expenses reached $135.0 million in Q4 2025 per HAE's latest filing, down from $136.3 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $146.0 million in Q1 2024 and bottomed at $98.0 million in Q4 2021.
  • Average Operating Expenses over 5 years is $122.5 million, with a median of $121.4 million recorded in 2023.
  • Peak YoY movement for Operating Expenses: surged 108.75% in 2021, then decreased 16.61% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $98.0 million in 2021, then rose by 17.75% to $115.4 million in 2022, then rose by 14.26% to $131.9 million in 2023, then increased by 1.99% to $134.5 million in 2024, then grew by 0.35% to $135.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $135.0 million in Q4 2025, $136.3 million in Q3 2025, and $138.4 million in Q2 2025.